Loading...
Podoplanin: An emerging cancer biomarker and therapeutic target
Podoplanin (PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression. In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migratio...
Na minha lista:
| Udgivet i: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980289/ https://ncbi.nlm.nih.gov/pubmed/29575529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13580 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|